Kuwayama H et al. |
Rabeprazole-based eradication therapy for Helicobacter pylori: a large-scale study in Japan. |
2007 |
Aliment. Pharmacol. Ther. |
pmid:17439512
|
Van Oijen AH et al. |
Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930892
|
Hurenkamp GJ et al. |
Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930901
|
Gisbert JP et al. |
Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12641497
|
Wong BC et al. |
Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11380322
|
Nada T et al. |
DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:15298604
|
Kaneko F et al. |
High prevalence rate of Helicobacter pylori resistance to clarithromycin during long-term multiple antibiotic therapy for chronic respiratory disease caused by non-tuberculous mycobacteria. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:15298607
|
de Francesco V et al. |
Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction. |
2006 |
Aliment. Pharmacol. Ther. |
pmid:16423002
|
Lamouliatte H et al. |
Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10571611
|
Wong WM et al. |
One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11929398
|
Kim JS et al. |
Effect of Helicobacter pylori eradication on duodenal ulcer scar in patients with no clinical history of duodenal ulcer. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11860410
|
Isomoto H et al. |
5-day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11121910
|
Canducci F et al. |
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11121911
|
Pilotto A et al. |
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971305
|
Gisbert JP et al. |
Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients. |
2006 |
Aliment. Pharmacol. Ther. |
pmid:16556172
|
Kawabata H et al. |
Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12534411
|
Catalano F et al. |
Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11012478
|
Gomollón F et al. |
Third line treatment for Helicobacter pylori: a prospective, culture-guided study in peptic ulcer patients. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11012479
|
De Francesco V et al. |
Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:14871280
|
Koivisto TT et al. |
First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens. |
2005 |
Aliment. Pharmacol. Ther. |
pmid:15771764
|